Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.77%
#2 DMT-NAT DMT-NAT +9.23%
#3 B3 (Base) B3 (Base) +8.58%
#4 Ontology Gas Ontology Gas +7.93%
#5 Provenance Blockchain Provenance Blockchain +6.68%
#6 Janction Janction +6.54%
#7 GoPlus Security GoPlus Security +5.97%
#8 Everything Everything +5.64%
#9 Status Status +4.28%
#10 The Bitcoin Bull The Bitcoin Bull +4.04%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
設定
言語
日本
通貨
USD
テーマ
PJSC Pharmsynthez PJSC Pharmsynthez

PJSC Pharmsynthez

LIFE
株式のランク #34086
PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation,... PJSC Pharmsynthez, a pharmaceutical enterprise, focuses on the investigation, production, and supply of both proprietary (officinal) and generic active pharmaceutical ingredients across Russia and the Commonwealth of Independent States (CIS). Its portfolio of branded medicines includes Neovir, Segidrin, Fenasid, and Penkrofton, which are employed in critical therapeutic areas such as oncology, gynecology, the management of immune deficiencies, and tuberculosis. Public Joint-Stock Company Pharmsynthez has also established a collaboration with HiFiBiO Therapeutics Inks for the clinical advancement and market introduction of their SARS-CoV-2 neutralizing antibody within Russia. The company, which began operations in 1996, is headquartered in St. Petersburg, Russia.
株価
$0.02082992
最終同期: 2026-08-14
時価総額
$6.27M
変化（1日）
-3.31%
変化（1年）
-51.62%
国
RU
取引 PJSC Pharmsynthez (LIFE)

カテゴリー

Healthcare
PJSC Pharmsynthez（LIFE）のEPS
2026 時点のEPS TTM: 0
PJSC Pharmsynthezの最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
PJSC PharmsynthezのEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE